Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Venous Thrombosis

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 34 articles: HTML format

Single Articles

June 2026
1. CASTELLUCCI LA, Le Gal G, Rodger M
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. Reply.
   N Engl J Med. 2026;394:2278-2279.
   PubMed    
   
   
   
2. DESAI N
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
   N Engl J Med. 2026;394:2278.
   PubMed    
   
   
   
3. EDJIMBI J, Bakhshi H, Van Spall HGC
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
   N Engl J Med. 2026;394:2278.
   PubMed    
   
   
   
4. BRENNER MJ
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
   N Engl J Med. 2026;394:2277-2278.
   PubMed    
   
   
   
5. HARTEMINK J, Parker K, Mitra S
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
   N Engl J Med. 2026;394:2277.
   PubMed    
   
   
   
6. ADNAN N, Uzair K, Patel MJ
   Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
   N Engl J Med. 2026;394:2276-2277.
   PubMed    
   
   
   March 2026
7. ROSENFIELD K, Klok FA, Piazza G, Sharp ASP, et al
   Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
   N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2516567.
   PubMed     Abstract available
   
   
   
8. SPYROPOULOS AC, Vedantham S
   Advanced Therapy for Intermediate-Risk Pulmonary Embolism.
   N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMe2603115.
   PubMed    
   
   
   
9. MOORES LK
   The COBRRA Trial - Ending the Venous Thromboembolism Safety Toss-up.
   N Engl J Med. 2026;394:1123-1124.
   PubMed    
   
   
   
10. CASTELLUCCI LA, Chen VM, Kovacs MJ, Lazo-Langner A, et al
    Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
    N Engl J Med. 2026;394:1051-1060.
    PubMed     Abstract available
    
    
    December 2025
11. PIAZZA G
    Extended Treatment of Provoked Venous Thromboembolism. Reply.
    N Engl J Med. 2025;393:2381.
    PubMed    
    
    
    
12. TAZI MEZALEK Z
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2380-2381.
    PubMed    
    
    
    
13. CALVELLO J
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2380.
    PubMed    
    
    
    
14. JACOB SCB, Benedetto IG, Gazzana MB
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2380.
    PubMed    
    
    
    
15. DEMIRCI SAHIN A, Sahin U
    Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025;393:2379.
    PubMed    
    
    
    August 2025
16. PIAZZA G, Bikdeli B, Pandey AK, Krishnathasan D, et al
    Apixaban for Extended Treatment of Provoked Venous Thromboembolism.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509426.
    PubMed     Abstract available
    
    
    July 2025
17. MAHE I, Carrier M, Laporte S
    Apixaban for Cancer-Associated Venous Thromboembolism. Reply.
    N Engl J Med. 2025;393:311-312.
    PubMed    
    
    
    
18. CONTEDUCA V, Giordano G, Landriscina M
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:310-311.
    PubMed    
    
    
    
19. DING YJ, Huang K, Li QY
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:310.
    PubMed    
    
    
    
20. WU G, Liu W, Sheung L
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:310.
    PubMed    
    
    
    
21. SHAO Z, Zhai X
    Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025;393:309.
    PubMed    
    
    
    March 2025
22. NOBLE S
    Cancer-Associated Venous Thromboembolism - Beyond 6 Months.
    N Engl J Med. 2025 Mar 29. doi: 10.1056/NEJMe2503460.
    PubMed    
    
    
    
23. MAHE I, Carrier M, Mayeur D, Chidiac J, et al
    Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
    N Engl J Med. 2025 Mar 29. doi: 10.1056/NEJMoa2416112.
    PubMed     Abstract available
    
    
    January 2025
24. SHIMOYAMA Y, Tomoda Y
    Westermark's Sign and Palla's Sign in Pulmonary Embolism.
    N Engl J Med. 2025;392:e2.
    PubMed    
    
    
    August 2024
25. HERON MJ, Deng F
    Lemierre's Syndrome Complicated by Cavernous Sinus Thrombosis.
    N Engl J Med. 2024;391:e12.
    PubMed    
    
    
    November 2023
26. DALY S, Cassidy T
    Thrombus in Transit across a Patent Foramen Ovale.
    N Engl J Med. 2023;389:e45.
    PubMed    
    
    
    July 2023
27. SMYTH R, Kabrhel C, Morris T
    Treatment of Intermediate-Risk Pulmonary Embolism.
    N Engl J Med. 2023;389:184-187.
    PubMed    
    
    
    April 2023
28. O'HARA NN, Stein DM, O'Toole RV
    Aspirin for Thromboprophylaxis after a Fracture. Reply.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
29. VAN TWIST DJL, Luu IHY, Ten Cate H
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
30. AHUJA T, Green D
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
31. YOSHINO T, Yamada Y, Tamura Y
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
32. WU XD, Min J
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    
33. SOURMELIS S, Zagoreos N
    Aspirin for Thromboprophylaxis after a Fracture.
    N Engl J Med. 2023;388:e57.
    PubMed    
    
    
    March 2023
34. JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al
    Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
    N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum